Hosokawa, Tomonari
Miyaji, Chikara
Yoshimura, Yusaku
Washida, Kenji
Yada, Yuji
Sakamoto, Shinji
Okahisa, Yuko
Takao, Soshi
Nomura, Akira
Kishi, Yoshiki
Harada, Toshiki
Takaki, Manabu http://orcid.org/0000-0002-7371-2821
Takeda, Toshihiko
Yamada, Norihito
Article History
Received: 24 December 2022
Accepted: 12 June 2023
First Online: 17 July 2023
Declarations
:
: N.Y. has received unrestricted research funding from Daiichi Sankyo, Eisai, Pfizer, Otsuka, Astellas, and Merck Sharp & Dohme, which was deposited into research accounts at Okayama University. N.Y. has received honoraria for his participation as a speaker at educational events from UCB Japan, Tsumura, Pfizer, Dainippon-Sumitomo, Daiichi-Sankyo, Merck Sharp & Dohme, Pfizer, Eisai, Meiji-Seika, and Mochida.M.T. has received honoraria for his participation as a speaker at education events sponsored by Daiichi Sankyo, Takeda, Tsumura, Otsuka, and Dainippon Sumitomo.Y. Yada has received honoraria for speaking at educational events sponsored by Novartis, Otsuka, and Dainippon Sumitomo.S.S. has received unrestricted research funding from Eli Lilly, which was deposited into research accounts at Okayama University Hospital. S.S. has received honoraria for his participation as a speaker at an educational event sponsored by Otsuka and Meiji-Seika.Y.K. has received honoraria for his participation as a speaker at educational events sponsored by Novartis and Dainippon Sumitomo.T. Hosokawa, C.M., Y. Yoshimura, Y.O., K. Washida, S.T., A.N., T. Harada, and T.T. report no additional financial or other relationship relevant to this article.